ASND insider transaction filings
Ascendis Pharma A/S — 6 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen ASND transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | BIENAIME JEAN JACQUES — Director | Purchase (P): 1,100 @ $245.85 · Purchase (P): 900 @ $246.91 | EDGAR |
| 2026-06-02 | 4 | SMITH SCOTT THOMAS — EVP & Chief Financial Officer | Purchase (P): 100 @ $219 | EDGAR |
| 2026-06-01 | 4 | SMITH SCOTT THOMAS — EVP & Chief Financial Officer | Purchase (P): 250 @ $223.32 | EDGAR |
| 2026-06-01 | 4 | BIENAIME JEAN JACQUES — Director | Purchase (P): 200 @ $223.76 · Purchase (P): 200 @ $222.30 · Purchase (P): 100 @ $223.50 | EDGAR |
| 2026-05-27 | 4 | BIENAIME JEAN JACQUES — Director | Purchase (P): 200 @ $236.24 · Purchase (P): 200 @ $239.37 | EDGAR |
| 2026-05-12 | 4 | JENSEN FLEMMING STEEN — See Remarks | Sale (S): 19,460 @ $238.49 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ASND returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →